Great West Life Assurance Co. Can lessened its stake in Cantel Medical Corp. (NYSE:CMD) by 8.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 48,251 shares of the company’s stock after selling 4,420 shares during the quarter. Great West Life Assurance Co. Can owned approximately 0.12% of Cantel Medical worth $4,387,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Globeflex Capital L P bought a new stake in Cantel Medical in the 2nd quarter valued at $114,000. Airain ltd bought a new stake in Cantel Medical in the 2nd quarter valued at $201,000. Punch & Associates Investment Management Inc. bought a new stake in Cantel Medical in the 2nd quarter valued at $212,000. Riverhead Capital Management LLC bought a new stake in Cantel Medical in the 2nd quarter valued at $218,000. Finally, World Asset Management Inc bought a new stake in Cantel Medical in the 3rd quarter valued at $224,000. 84.98% of the stock is owned by institutional investors.

Separately, Needham & Company LLC reiterated a “hold” rating on shares of Cantel Medical in a research report on Friday, September 1st. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Cantel Medical currently has an average rating of “Hold” and an average price target of $91.67.

Cantel Medical Corp. (NYSE CMD) opened at $99.50 on Friday. The company has a current ratio of 2.44, a quick ratio of 1.49 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $4,456.71, a price-to-earnings ratio of 49.81 and a beta of 1.24. Cantel Medical Corp. has a 12-month low of $69.21 and a 12-month high of $108.00.

Cantel Medical (NYSE:CMD) last issued its quarterly earnings results on Thursday, September 28th. The company reported $0.54 EPS for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.02. Cantel Medical had a return on equity of 17.42% and a net margin of 9.50%. The company had revenue of $205.50 million for the quarter, compared to analysts’ expectations of $200.32 million. The company’s revenue was up 14.8% compared to the same quarter last year. sell-side analysts forecast that Cantel Medical Corp. will post 2.34 earnings per share for the current fiscal year.

The business also recently declared a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Investors of record on Wednesday, January 17th will be given a $0.085 dividend. The ex-dividend date is Tuesday, January 16th. This represents a dividend yield of 0.17%. This is a boost from Cantel Medical’s previous Semi-Annual dividend of $0.07. Cantel Medical’s dividend payout ratio (DPR) is presently 8.19%.

In related news, EVP Eric W. Nodiff sold 2,868 shares of the firm’s stock in a transaction dated Friday, October 20th. The stock was sold at an average price of $97.55, for a total value of $279,773.40. Following the sale, the executive vice president now directly owns 39,102 shares of the company’s stock, valued at $3,814,400.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Mark N. Diker sold 7,000 shares of the firm’s stock in a transaction dated Tuesday, October 3rd. The shares were sold at an average price of $98.90, for a total value of $692,300.00. The disclosure for this sale can be found here. Insiders sold 36,368 shares of company stock worth $3,576,028 in the last 90 days. 12.30% of the stock is owned by company insiders.

WARNING: “Cantel Medical Corp. (CMD) Stake Lowered by Great West Life Assurance Co. Can” was first reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at

About Cantel Medical

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Want to see what other hedge funds are holding CMD? Visit to get the latest 13F filings and insider trades for Cantel Medical Corp. (NYSE:CMD).

Institutional Ownership by Quarter for Cantel Medical (NYSE:CMD)

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.